Biomarkers for the Assessment of Stroke/Systemic Embolism and Bleeding Risk in Patients With Atrial Fibrillation: A Nested Observational Study From ENGAGE AF-TIMI 48

被引：0
|
作者：
Berg, David D. [1 ]
Ruff, Christian T. [1 ]
Jarolim, Petr [2 ]
Giugliano, Robert P. [1 ]
Nordio, Francesco [1 ]
Lanz, Hans J. [3 ]
Mercuri, Michele [4 ]
Grosso, Michael [5 ]
Antman, Elliott M. [1 ]
Braunwald, Eugene [1 ]
Morrow, David A. [1 ]
机构：
[1] Brigham & Womens Hosp, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Pathol, 75 Francis St, Boston, MA 02115 USA
[3] Dauchi Sankyo, Global Med Affairs, Munich, Germany
[4] Daiichi Sankyo, Pharma Dev, Basking Ridge, NJ USA
[5] Daiichi Sankyo, Cardiovasc Clin Dev, Basking Ridge, NJ USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Atrial fibrillation; Biomarkers; Stroke; Anticoagulation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14367
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF-TIMI 48 Trial
    Fanola, Christina L.
    Ruff, Christian T.
    Murphy, Sabina A.
    Jin, James
    Duggal, Anil
    Babilonia, Noe A.
    Sritara, Piyamitr
    Mercuri, Michele F.
    Kamphuisen, Pieter W.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (16):
  • [32] Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial
    Nicolau, Andre M.
    Corbalan, Ramon
    Nicolau, Jose C.
    Ruff, Christian T.
    Zierhut, Wolfgang
    Kerschnitzki, Michael
    Duris, Tibor
    Juul-Moller, Steen
    Voitk, Juri
    Trevisan, Marco
    Nordio, Francesco
    Antman, Elliott M.
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (03) : 167 - 175
  • [33] Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation The ENGAGE AF-TIMI 48 Trial
    Ruff, Christian T.
    Giugliano, Robert P.
    Braunwald, Eugene
    Mercuri, Michele
    Curt, Valentin
    Betcher, Joshua
    Grip, Laura
    Cange, Abby L.
    Crompton, Andrea E.
    Murphy, Sabina A.
    Deenadayalu, Naveen
    Antman, Elliott M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (06) : 576 - 584
  • [34] External validation of AF-BLEED for predicting major bleeding and for tailoring NOAC dose in AF patients: A post hoc analysis in the ENGAGE AF-TIMI 48
    Chu, G.
    Valerio, L.
    Barco, S.
    Huisman, M. V.
    Konstantinides, S. V.
    Klok, F. A.
    THROMBOSIS RESEARCH, 2023, 229 : 225 - 231
  • [35] Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
    Boriani, Giuseppe
    Ruff, Christian T.
    Kuder, Julia F.
    Shi, Minggao
    Lanz, Hans J.
    Rutman, Howard
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL, 2019, 40 (19) : 1541 - +
  • [36] Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial
    Nelson, Sarah E.
    Giugliano, Robert P.
    Antman, Elliott M.
    Park, Jeong-Gun
    Norden, Andrew D.
    Rost, Natalia S.
    Silverman, Scott
    Singhal, Aneesh B.
    Lanz, Hans J.
    Braunwald, Eugene
    Ruff, Christian T.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 86 : 294 - 300
  • [37] Efficacy and Safety of Oral Anticoagulation in 21105 Patients With Atrial Fibrillation Stratified by Diabetic Status in the ENGAGE AF-TIMI 48 Trial
    Plitt, Anna
    Ruff, Christian
    Goudev, Assen
    Morais, Joao
    Park, Jeong-Gun
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    CIRCULATION, 2016, 134
  • [38] Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
    Ruff, Christian T.
    Giugliano, Robert P.
    Braunwald, Eugene
    Murphy, Sabina A.
    Brown, Karen
    Jarolim, Petr
    Mercuri, Michele
    Antman, Elliott M.
    Morrow, David A.
    JAMA CARDIOLOGY, 2016, 1 (09) : 999 - 1006
  • [39] Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial
    Eisen, Alon
    Ruff, Christian T.
    Braunwald, Eugene
    Hamershock, Rose A.
    Lewis, Basil S.
    Hassager, Christian
    Chao, Tze-Fan
    Le Heuzey, Jean Yves
    Mercuri, Michele
    Rutman, Howard
    Antman, Elliott M.
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (07):
  • [40] High-Dose Edoxaban Regimen versus Warfarin in Patients With Atrial Fibrillation and Established Coronary Artery Disease: Insights From the ENGAGE AF-TIMI 48 Trial
    Zelniker, Thomas A.
    Ruff, Christian T.
    Wiviott, Stephen D.
    Blanc, Jean-Jacques
    Nordio, Francesco
    Mercuri, Michele F.
    Lanz, Hans
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    CIRCULATION, 2017, 136
12345